JP2020504130A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020504130A5 JP2020504130A5 JP2019536487A JP2019536487A JP2020504130A5 JP 2020504130 A5 JP2020504130 A5 JP 2020504130A5 JP 2019536487 A JP2019536487 A JP 2019536487A JP 2019536487 A JP2019536487 A JP 2019536487A JP 2020504130 A5 JP2020504130 A5 JP 2020504130A5
- Authority
- JP
- Japan
- Prior art keywords
- nanoconjugate
- cancer
- dtdtpa
- thioctic acid
- doxorubicin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762444114P | 2017-01-09 | 2017-01-09 | |
| US62/444,114 | 2017-01-09 | ||
| PCT/US2018/012882 WO2018129501A1 (en) | 2017-01-09 | 2018-01-09 | Targeted doxorubicin-gold nanoconjugates for tumor therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020504130A JP2020504130A (ja) | 2020-02-06 |
| JP2020504130A5 true JP2020504130A5 (OSRAM) | 2021-02-04 |
| JP7017258B2 JP7017258B2 (ja) | 2022-02-08 |
Family
ID=62791162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019536487A Expired - Fee Related JP7017258B2 (ja) | 2017-01-09 | 2018-01-09 | 腫瘍治療のための標的化されたドキソルビシン－金ナノコンジュゲート |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210015944A1 (OSRAM) |
| EP (1) | EP3568694B1 (OSRAM) |
| JP (1) | JP7017258B2 (OSRAM) |
| KR (1) | KR102568577B1 (OSRAM) |
| CN (1) | CN110178028B (OSRAM) |
| AU (1) | AU2018205349B2 (OSRAM) |
| BR (1) | BR112019013469A2 (OSRAM) |
| CA (1) | CA3048908A1 (OSRAM) |
| ES (1) | ES2912286T3 (OSRAM) |
| MX (1) | MX2019008233A (OSRAM) |
| WO (1) | WO2018129501A1 (OSRAM) |
| ZA (1) | ZA201904736B (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101887421B1 (ko) * | 2016-09-20 | 2018-08-13 | 김문혜 | 체인 구동형 유기질비료 발효 건조장치 |
| CN113797353B (zh) * | 2020-06-12 | 2023-10-20 | 南京工业大学 | 一种放化疗联合治疗试剂及其制备方法 |
| CN112494660B (zh) * | 2020-12-22 | 2023-11-21 | 上海交通大学 | 纳米靶向药物的制备方法及在治疗胃癌中的应用 |
| EP4526067A4 (en) | 2022-05-17 | 2026-03-25 | Us Gov Sec Navy | GERM-FREE SYNTHESIS OF ANISOTROPIC GOLD NANOFLOWERS FOR CELL CONTROL AND DRUG DELIVERY APPLICATIONS |
| WO2023242766A1 (en) | 2022-06-15 | 2023-12-21 | Alembic Pharmaceuticals Limited | Gold nanoconjugates |
| CN120713846B (zh) * | 2025-07-14 | 2026-03-31 | 湖南省妇幼保健院 | 基于铜离子和多柔比星的纳米级配位聚合物NP@DoxCu及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101563360A (zh) * | 2006-10-20 | 2009-10-21 | 益普生制药两合公司 | 肽-细胞毒性缀合物 |
| US20100021471A1 (en) * | 2008-07-25 | 2010-01-28 | Brookhaven Science Associates, Llc | Carbon nanotube-based drug delivery systems and methods of making same |
| WO2010014812A2 (en) * | 2008-07-30 | 2010-02-04 | The Research Foundation Of State University Of New York | Peptide compositions and methods of use |
| KR101196667B1 (ko) * | 2010-04-15 | 2012-11-02 | 포항공과대학교 산학협력단 | 피에이치 민감성 금속 나노 입자를 이용한 항암제 전달 시스템 |
| US9605304B2 (en) * | 2011-07-20 | 2017-03-28 | The Hong Kong Polytechnic University | Ultra-stable oligonucleotide-gold and-silver nanoparticle conjugates and method of their preparation |
| WO2014130429A2 (en) * | 2013-02-19 | 2014-08-28 | National Health Research Institutes | Caged platinum nanoclusters for anticancer chemotherapeutics |
| HUE050462T2 (hu) * | 2013-12-30 | 2020-12-28 | Univ Missouri | Au többkomponensû nanoanyagok és szintézis eljárások |
-
2018
- 2018-01-09 MX MX2019008233A patent/MX2019008233A/es unknown
- 2018-01-09 US US16/478,999 patent/US20210015944A1/en not_active Abandoned
- 2018-01-09 BR BR112019013469-7A patent/BR112019013469A2/pt not_active Application Discontinuation
- 2018-01-09 KR KR1020197019628A patent/KR102568577B1/ko active Active
- 2018-01-09 AU AU2018205349A patent/AU2018205349B2/en not_active Ceased
- 2018-01-09 JP JP2019536487A patent/JP7017258B2/ja not_active Expired - Fee Related
- 2018-01-09 ES ES18736294T patent/ES2912286T3/es active Active
- 2018-01-09 CN CN201880006184.9A patent/CN110178028B/zh not_active Expired - Fee Related
- 2018-01-09 EP EP18736294.2A patent/EP3568694B1/en active Active
- 2018-01-09 CA CA3048908A patent/CA3048908A1/en active Pending
- 2018-01-09 WO PCT/US2018/012882 patent/WO2018129501A1/en not_active Ceased
-
2019
- 2019-07-18 ZA ZA2019/04736A patent/ZA201904736B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hoonjan et al. | Arsenic trioxide: insights into its evolution to an anticancer agent | |
| Fabbro et al. | Targeting carbon nanotubes against cancer | |
| CN102686243B (zh) | 用于抗癌剂递送的聚合物系统 | |
| ES2826398T3 (es) | Enlazadores-fármacos pegilados para una mejor farmacocinética de los conjugados ligando-fármaco | |
| JP2017521486A5 (OSRAM) | ||
| KR101705077B1 (ko) | Ｈｐｍａ-도세탁셀 또는 젬시타빈 컨쥬게이트 및 이의 용도 | |
| ES2697348T3 (es) | Péptidos y conjugados de principio activo-péptido para direccionamiento renal | |
| CN110178028B (zh) | 用于肿瘤治疗的靶向阿霉素-金纳米缀合物 | |
| JP2018509394A5 (OSRAM) | ||
| HRP20200721T1 (hr) | Aktivirajuća anti-cd166 antitijela i postupci njihove uporabe | |
| JP2021535209A5 (OSRAM) | ||
| ME02919B (me) | Konjugati humanog antitijela sa lijekom protiv tkivnog faktora | |
| HRP20110551T1 (hr) | Antagonisti cikličkog peptida cxcr4 | |
| JP2012505922A5 (OSRAM) | ||
| EP3089997B1 (en) | Au multicomponent nanomaterials and synthesis methods | |
| JP2010535811A5 (OSRAM) | ||
| Rizvi et al. | Engineering peptide drug therapeutics through chemical conjugation and implication in clinics | |
| JP2022533671A5 (OSRAM) | ||
| Appiah et al. | Acid-responsive HPMA copolymer-bradykinin conjugate enhances tumor-targeted delivery of nanomedicine | |
| WO2018078648A4 (en) | Gold nanoparticle based formulation for use in cancer therapy | |
| CN116917278A (zh) | 用于靶向递送应用的二价成纤维细胞活化蛋白配体 | |
| Alcantara et al. | A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy | |
| Wang et al. | New trends and future developments of platinum‐based antitumor drugs | |
| DE50212918D1 (de) | Polypeptid, dessen konjugat doxorubicin enthält, uetzung | |
| US11591357B2 (en) | Payload and linker designs for platinum-acridine anticancer agents and methods thereof |